Nuclear magnetic resonance imaging in patients with cardiac pacing devices
- PMID: 20515632
- DOI: 10.1016/s1885-5857(10)70149-3
Nuclear magnetic resonance imaging in patients with cardiac pacing devices
Abstract
Currently, nuclear magnetic resonance imaging is contraindicated in patients with a pacemaker or implantable cardioverter-defibrillator. This study was carried out because the potential risks in this situation need to be clearly defined. This prospective study evaluated clinical and electrical parameters before and after magnetic resonance imaging was performed in 33 patients (five with implantable cardioverter-defibrillators and 28 with pacemakers). In these patients, magnetic resonance imaging was considered clinically essential. There were no clinical complications. There was a temporary communication failure in two cases, sensing errors during imaging in two cases, and a safety signal was generated in one pacemaker at the maximum magnetic resonance frequency and output level. There were no technical restrictions on imaging nor were there any permanent changes in the performance of the cardiac pacing device.
Similar articles
-
Implications of pacemakers and implantable cardioverter defibrillators in urological practice.J Urol. 2011 Oct;186(4):1198-205. doi: 10.1016/j.juro.2011.02.2697. Epub 2011 Aug 16. J Urol. 2011. PMID: 21849189 Review.
-
Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.Am J Cardiol. 2012 Dec 1;110(11):1631-6. doi: 10.1016/j.amjcard.2012.07.030. Epub 2012 Aug 23. Am J Cardiol. 2012. PMID: 22921995
-
Safety and utility of magnetic resonance imaging in patients with cardiac implantable electronic devices.Heart Rhythm. 2017 Aug;14(8):1138-1144. doi: 10.1016/j.hrthm.2017.03.039. Epub 2017 Apr 3. Heart Rhythm. 2017. PMID: 28385671 Free PMC article.
-
Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.Am Heart J. 2013 Mar;165(3):266-72. doi: 10.1016/j.ahj.2012.12.004. Epub 2013 Jan 28. Am Heart J. 2013. PMID: 23453091
-
Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations.Braz J Anesthesiol. 2014 May-Jun;64(3):205-14. doi: 10.1016/j.bjane.2013.02.005. Epub 2013 Oct 16. Braz J Anesthesiol. 2014. PMID: 24907883 Review.
Cited by
-
Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.N Engl J Med. 2017 Dec 28;377(26):2555-2564. doi: 10.1056/NEJMoa1604267. N Engl J Med. 2017. PMID: 29281579 Free PMC article.
-
Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs.J Cardiovasc Magn Reson. 2011 Oct 27;13(1):63. doi: 10.1186/1532-429X-13-63. J Cardiovasc Magn Reson. 2011. PMID: 22032338 Free PMC article. Review.
-
The Kora Pacemaker is Safe and Effective for Magnetic Resonance Imaging.Clin Med Insights Cardiol. 2015 Aug 12;9:85-90. doi: 10.4137/CMC.S24976. eCollection 2015. Clin Med Insights Cardiol. 2015. PMID: 26327785 Free PMC article.
-
An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.Eur Radiol. 2018 Jun;28(6):2406-2416. doi: 10.1007/s00330-017-5098-z. Epub 2018 Jan 9. Eur Radiol. 2018. PMID: 29318430 Clinical Trial.
-
Magnetic resonance imaging interactions with a sacral neuromodulation system.Neurourol Urodyn. 2021 Nov;40(8):1862-1868. doi: 10.1002/nau.24756. Epub 2021 Sep 6. Neurourol Urodyn. 2021. PMID: 34487571 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical